Cargando…
A peptidomimetic modulator of the Ca(V)2.2 N-type calcium channel for chronic pain
Transmembrane Ca(v)2.2 (N-type) voltage-gated calcium channels are genetically and pharmacologically validated, clinically relevant pain targets. Clinical block of Ca(v)2.2 (e.g., with Prialt/Ziconotide) or indirect modulation [e.g., with gabapentinoids such as Gabapentin (GBP)] mitigates chronic pa...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666126/ https://www.ncbi.nlm.nih.gov/pubmed/37972067 http://dx.doi.org/10.1073/pnas.2305215120 |